Showing results (1321-1330 of 1,519) with videos related to
Sort By:
Pageof 152
Familial Cancer|January 6, 2012
The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancerYael Laitman, Liron Herskovitz, Talia Golan, et al.Familial Cancer|December 14, 2011
A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyadRicardo Celestino, Jorge Lima, Alexandra Faustino, et al.Familial Cancer|March 8, 2012
Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromesAdam Andreasson, Luqman Sulaiman, Sónia do Vale, et al.Familial Cancer|March 16, 2012
The evolution of personalized cancer genetic counseling in the era of personalized medicineHetal S Vig, Catharine WangFamilial Cancer|December 20, 2019
The (ir)relevance of the abandoned criterion II for the diagnosis of serrated polyposis syndrome: a retrospective cohort studyArne G C Bleijenberg, Joep E G IJspeert, Daniel Rodríguez-Alcalde, et al.Familial Cancer|December 21, 2019
De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancerRinat Bernstein Molho, Shelly Zalmanoviz, Yael Laitman, et al.Familial Cancer|March 16, 2020
Lack of evidence for CDK12 as an ovarian cancer predisposing geneAlexandre Eeckhoutte, Mathilde Saint-Ghislain, Manon Reverdy, et al.Familial Cancer|January 29, 2019
Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer careNina Hallowell, S Wright, D Stirling, et al.Familial Cancer|November 2, 2019
Clear cell chondrosarcoma in Von Hippel-Lindau diseaseKoen M A Dreijerink, Rachel S van Leeuwaarde, Wenzel M Hackeng, et al.Familial Cancer|November 28, 2019
'We don't know for sure': discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultationsNiki M Medendorp, Marij A Hillen, Pomme E A van Maarschalkerweerd, et al.Pageof 152